Twist Bioscience Files 8-K on Shareholder Vote Submission

TL;DR

**Twist Bioscience just held a shareholder vote, expect results soon!**

AI Summary

Twist Bioscience Corporation filed an 8-K on February 7, 2024, to report that it submitted matters to a vote of security holders on February 6, 2024. This filing indicates that the company held its annual meeting or a special meeting where shareholders voted on various proposals. For investors, this matters because the outcomes of these votes, which are not detailed in this specific 8-K, could impact the company's governance, executive compensation, or strategic direction, potentially affecting stock performance.

Why It Matters

This filing signals that Twist Bioscience shareholders have recently voted on important company matters, the results of which will be disclosed in a future filing and could influence the company's future operations and investor confidence.

Risk Assessment

Risk Level: low — This filing is purely procedural, reporting the submission of matters to a vote, and does not contain any information that directly impacts the company's financial health or operations.

Analyst Insight

A smart investor would monitor future 8-K filings or proxy statements from Twist Bioscience for the actual results of the shareholder vote, as these outcomes could influence governance and strategic decisions.

Key Players & Entities

• Twist Bioscience Corporation (company) — the registrant filing the 8-K
• February 6, 2024 (date) — date of earliest event reported (submission of matters to a vote)
• February 7, 2024 (date) — date the 8-K was filed
• 001-38720 (other) — Commission File Number for Twist Bioscience
• TWST (other) — Trading Symbol for Twist Bioscience Common Stock
• The Nasdaq Global Select Market (other) — exchange where Twist Bioscience Common Stock is registered

FAQ

Filing Documents

• tm245414d1_8k.htm (8-K) — 37KB
• 0001104659-24-011607.txt ( ) — 205KB
• twst-20240206.xsd (EX-101.SCH) — 3KB
• twst-20240206_lab.xml (EX-101.LAB) — 33KB
• twst-20240206_pre.xml (EX-101.PRE) — 22KB
• tm245414d1_8k_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. The 2024 Annual Meeting of Stockholders of Twist Bioscience Corporation (the "Company") was held on February 6, 2024 (the "Annual Meeting"). At the Annual Meeting, there were present, in person or by proxy, holders of 52,300,164 shares of common stock, or approximately 90.51% of the total outstanding shares eligible to be voted. The holders present voted on the three proposals presented at the Annual Meeting as follows. Proposal One — Election of Directors The Company's stockholders approved the election of two directors to the Company's Board of Directors as Class III Directors by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Emily M. Leproust, Ph.D. 33,957,330 12,194,829 6,148,005 Robert Chess 27,503,789 18,648,370 6,148,005 Proposal Two — Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs") The Company's stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of the Company's NEOs by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 43,215,571 2,904,714 31,874 6,148,005 Proposal Three — Ratification of Appointment of Independent Registered Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered accounting firm for the fiscal year ending September 30, 2024 by the following votes: Votes For Votes Against Abstentions 52,195,318 61,548 43,298

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 7, 2024 Twist Bioscience Corporation /s/ Judy Yan Judy Yan Assistant General Counsel and Assistant Secretary

View Full Filing

View this 8-K filing on SEC EDGAR